Temporal Stability in Chronic Wound Microbiota Is Associated With Poor Healing

Michael Loesche, Sue E Gardner, Lindsay Kalan, Joseph Horwinski, Qi Zheng, Brendan P Hodkinson, Amanda S Tyldsley, Carrie L Franciscus, Stephen L Hillis, Samir Mehta, David J Margolis, Elizabeth A Grice, Michael Loesche, Sue E Gardner, Lindsay Kalan, Joseph Horwinski, Qi Zheng, Brendan P Hodkinson, Amanda S Tyldsley, Carrie L Franciscus, Stephen L Hillis, Samir Mehta, David J Margolis, Elizabeth A Grice

Abstract

Microbial burden of chronic wounds is believed to play an important role in impaired healing and the development of infection-related complications. However, clinical cultures have little predictive value of wound outcomes, and culture-independent studies have been limited by cross-sectional design and small cohort size. We systematically evaluated the temporal dynamics of the microbiota colonizing diabetic foot ulcers, a common and costly complication of diabetes, and its association with healing and clinical complications. Dirichlet multinomial mixture modeling, Markov chain analysis, and mixed-effect models were used to investigate shifts in the microbiota over time and their associations with healing. Here we show, to our knowledge, previously unreported temporal dynamics of the chronic wound microbiome. Microbiota community instability was associated with faster healing and improved outcomes. Diabetic foot ulcer microbiota were found to exist in one of four community types that experienced frequent and nonrandom transitions. Transition patterns and frequencies were associated with healing time. Exposure to systemic antibiotics destabilized the wound microbiota, rather than altering overall diversity or relative abundance of specific taxa. This study provides evidence that the dynamic wound microbiome is indicative of clinical outcomes and may be a valuable guide for personalized management and treatment of chronic wounds.

Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Figure 1. The DFU microbiome clusters into…
Figure 1. The DFU microbiome clusters into four Community Types
(A) DFU samples partitioned into four clusters by Dirichlet multinomial mixture model. Mean relative abundances of bacterial taxa in DFU samples assigned to each Community Type. Relative abundance is shown on the Y-axis. Taxa are filtered to those with a mean abundance greater than 1%. (B) Sample similarity between DFU microbial communities were calculated using the Bray-Curtis distance and these distances were ordinated and visualized via non-metric multidimensional scaling (NMDS). Each taxonomic contribution to community differentiation is overlaid with black text and “x” indicating the exact location. The impacts of various metadata are depicted as vectors labeled with gray text. Success of NMDS ordination is represented by the stress score, which measures the agreement between the 2-D and multidimensional representations. Stress scores range from 0 to 1 and scores below 0.3 are considered good approximations. Samples, taxa, and metadata that are closer together are more related. Samples are color-coded based on community type.
Figure 2. DFU Community Types are dynamic
Figure 2. DFU Community Types are dynamic
(A) Per patient illustration of Community Type switching grouped by outcome. Depicted on the X-axis is visit number. Each row on the Y-axis represents a subject with a DFU. Colored boxes illustrate which Community Type was colonizing the DFU at the indicated visit number. Empty tiles represent a missed visit, whereas gray tiles indicate that a sample was not collected or available for analysis at that time point. The black diamonds indicate that the patient received antibiotics since the last visit. Only subjects that participated in >1 study visit are shown. (B) Markov chain visualization depicting the differential transition probabilities between community types of DFUs that healed in 12 weeks or did not. Each node represents a Community Type, arrows indicate the transition direction and probability (thickness), node size represents number of samples. Annotated are the self-transition probabilities.
Figure 3
Figure 3
Inter-visit Weighted UniFrac distances associations with healing time for subjects that healed during the study. X axes represent the study visit; study visits were 2 weeks apart. (A) Inter-visit distances are shown for each subject and depict a negative trend over time. Line and point colors represent the number of study visits that the ulcer persisted (red = 1, green = 8). Ulcers stabilize at a rate of −0.024/visit, but start at a lower rate in those ulcers that require more time to heal (−0.036 per visit required to heal). (B) Inter-visit distances between baseline and first study visit as a function of number of visits until healing. A negative correlation is found even within this initial comparison (R2 = 0.1601, p<0.0001).
Figure 4
Figure 4
Effects of antibiotics on microbial communities in DFUs. (A) Boxplot showing the inter-visit Weighted UniFrac distances of subjects during exposure to antibiotics split by indication. Antibiotics given for the ulcer being studied produces greater community disruption than antibiotics given for other ulcers or other infections. Antibiotic class did not yield more information. (B) Boxplot showing the inter-visit distances of all samples binned by event type (complication, antibiotics, both, or none). Antibiotics and ulcer complications both disrupt the microbiota, and their combined effect is additive.

References

    1. Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, et al. The burden of skin diseases: 2004. J Am Acad Dermatol. 2006 Sep;55(3):490–500.
    1. Brem H, Tomic-Canic M. Cellular and molecular basis of wound healing in diabetes. J Clin Invest. 2007 May;117(5):1219–22.
    1. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, et al. QIIME allows analysis of high-throughput community sequencing data. Nat Meth. 2010 May;7(5):335–6.
    1. Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. PNAS. 2011 Mar 15;108( Supplement 1):4554–61.
    1. DiGiulio DB, Callahan BJ, McMurdie PJ, Costello EK, Lyell DJ, Robaczewska A, et al. Temporal and spatial variation of the human microbiota during pregnancy. PNAS National Acad Sciences. 2015 Aug 17;112(35):201502875–11065.
    1. Ding T, Schloss PD. Dynamics and associations of microbial community types across the human body. Nature. 2014 May 15;509(7500):357–60.
    1. Dowd SE, Wolcott RD, Sun Y, McKeehan T, Smith E, Rhoads D. Polymicrobial Nature of Chronic Diabetic Foot Ulcer Biofilm Infections Determined Using Bacterial Tag Encoded FLX Amplicon Pyrosequencing (bTEFAP) In: Egles C, editor. PLoS ONE. 10. Vol. 3. Public Library of Science; 2008. Oct 3, p. e3326.
    1. Edgar RC. Bioinformatics. 19. Vol. 26. Oxford University Press; 2010. Oct 1, Search and clustering orders of magnitude faster than BLAST; pp. 2460–1.
    1. Flores GE, Caporaso J, Henley JB, Rideout J, Domogala D, Chase J, et al. Temporal variability is a personalized feature of the human microbiome. Genome Biol. 2014;15(12):531.
    1. Gardner SE, Frantz RA. Biol Res Nurs. 1. Vol. 10. SAGE Publications; 2008. Jul, Wound bioburden and infection-related complications in diabetic foot ulcers; pp. 44–53.
    1. Gardner SE, Frantz RA, Saltzman CL, Hillis SL, Park H, Scherubel M. Diagnostic validity of three swab techniques for identifying chronic wound infection. Wound Repair Regen. 2006 Sep;14(5):548–57.
    1. Gardner SE, Hillis SL, Heilmann K, Segre JA, Grice EA. The neuropathic diabetic foot ulcer microbiome is associated with clinical factors. Diabetes Am Diabetes Assoc. 2013;62(3):923–30.
    1. Glaudemans AWJM, Uçkay I, Lipsky BA. Challenges in diagnosing infection in the diabetic foot. Diabet Med. 2015 Jun;32(6):748–59.
    1. Gontcharova V, Youn E, Sun Y, Wolcott RD, Dowd SE. A comparison of bacterial composition in diabetic ulcers and contralateral intact skin. Open Microbiol J. 2010;4:8–19.
    1. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract. 2014 Feb;103(2):137–49.
    1. Holmes I, Harris K, Quince C. Dirichlet Multinomial Mixtures: Generative Models for Microbial Metagenomics. In: Gilbert JA, editor. PLoS ONE. 2. Vol. 7. 2012. Feb 3, p. e30126.
    1. Jenq RR, Ubeda C, Taur Y, Menezes CC, Khanin R, Dudakov JA, et al. J Exp Med. 5. Vol. 209. Rockefeller Univ Press; 2012. May 7, Regulation of intestinal inflammation by microbiota following allogeneic bone marrow transplantation; pp. 903–11.
    1. Keeney KM, Yurist-Doutsch S, Arrieta M-C, Finlay BB. Effects of antibiotics on human microbiota and subsequent disease. Annu Rev Microbiol. 2014;68(1):217–35.
    1. Lefcheck JS. piecewiseSEM: Piecewise structural equation modelling in r for ecology, evolution, and systematics. Methods Ecol Evol. 2016;7(5):573–9.
    1. Loïez C, Wallet F, Pischedda P, Renaux E, Senneville E, Mehdi N, et al. First case of osteomyelitis caused by “Staphylococcus pettenkoferi”. J Clin Microbiol American Society for Microbiology. 2007 Mar;45(3):1069–71.
    1. Margolis DJ, Berlin JA, Strom BL. Wound Repair Regen. 3. Vol. 4. Blackwell Science; 1996. Jul, Interobserver agreement, sensitivity, and specificity of a “healed” chronic wound; pp. 335–8.
    1. Martinez C, Antolin M, Santos J, Torrejon A, Casellas F, Borruel N, et al. Unstable composition of the fecal microbiota in ulcerative colitis during clinical remission. Am J Gastroenterol. 2008 Mar;103(3):643–8.
    1. Mayer BT, Srinivasan S, Fiedler TL, Marrazzo JM, Fredricks DN, Schiffer JT. Rapid and Profound Shifts in the Vaginal Microbiota Following Antibiotic Treatment for Bacterial Vaginosis. J Infect Dis. 2015 Aug 6;212(5):793–802.
    1. Meisel JS, Hannigan GD, Tyldsley AS, SanMiguel AJ, Hodkinson BP, Zheng Q, et al. Skin Microbiome Surveys Are Strongly Influenced by Experimental Design. J Invest Dermatol. 2016 May;136(5):947–56.
    1. Modi SR, Collins JJ, Relman DA. J Clin Invest. 10. Vol. 124. American Society for Clinical Investigation; 2014. Oct 1, Antibiotics and the gut microbiota; pp. 4212–8.
    1. Morgan XC, Kabakchiev B, Waldron L, Tyler AD, Tickle TL, Milgrom R, et al. Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biol BioMed Central. 2015;16(1):67.
    1. Pinheiro J, Bates D, DebRoy S, Sarkar D. R package version. 2007. Linear and nonlinear mixed effects models.
    1. Price LB, Liu CM, Melendez JH, Frankel YM, Engelthaler D, Aziz M, et al. Community analysis of chronic wound bacteria using 16S rRNA gene-based pyrosequencing: impact of diabetes and antibiotics on chronic wound microbiota. In: Ratner AJ, editor. PLoS ONE. 7. Vol. 4. 2009. p. e6462.
    1. Prompers L, Huijberts M, Apelqvist J, Jude E, Piaggesi A, Bakker K, et al. High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe. Baseline results from the Eurodiale study. Diabetologia. 2007 Jan;50(1):18–25.
    1. R Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: 2016. Available from: .
    1. Ramsey SD, Newton K, Blough D, McCulloch DK, Sandhu N, Reiber GE, et al. Incidence, outcomes, and cost of foot ulcers in patients with diabetes. Diabetes Care. 1999 Mar;22(3):382–7.
    1. Stein RR, Bucci V, Toussaint NC, Buffie CG, Rätsch G, Pamer EG, et al. Ecological Modeling from Time-Series Inference: Insight into Dynamics and Stability of Intestinal Microbiota. In: Mering von C, editor. PLoS Comput Biol. 12. Vol. 9. 2013. Dec 12, p. e1003388.
    1. Trülzsch K, Grabein B, Schumann P, Mellmann A, Antonenka U, Heesemann J, et al. Staphylococcus pettenkoferi sp. nov., a novel coagulase-negative staphylococcal species isolated from human clinical specimens. Int J Syst Evol Microbiol. 2007 Jul;57(Pt 7):1543–8.
    1. Valensi P, Girod I, Baron F, Moreau-Defarges T, Guillon P. Quality of life and clinical correlates in patients with diabetic foot ulcers. Diabetes & Metabolism. 2005 Jun;31(3):263–71.
    1. Wittebole X, De Roock S, Opal SM. A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens. Virulence Landes Bioscience. 2014 Jan 1;5(1):226–35.
    1. Wolcott RD, Hanson JD, Rees EJ, Koenig LD, Phillips CD, Wolcott RA, et al. Analysis of the chronic wound microbiota of 2,963 patients by 16S rDNA pyrosequencing. Wound Repair Regen. 2015 Oct 14; n/a–n/a.
    1. Zhang M, Jiang Z, Li D, Jiang D, Wu Y, Ren H, et al. Oral Antibiotic Treatment Induces Skin Microbiota Dysbiosis and Influences Wound Healing. Microb Ecol. 2014 Oct 10;69(2):415–21.

Source: PubMed

3
購読する